Jeff Cohen
Stock Analyst at Ladenburg Thalmann
(2.35)
# 2,319
Out of 4,814 analysts
11
Total ratings
55.56%
Success rate
8.49%
Average return
Main Sectors:
Stocks Rated by Jeff Cohen
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
CBLL CeriBell | Initiates: Buy | $32 | $14.86 | +115.34% | 1 | Apr 4, 2025 | |
BBNX Beta Bionics | Initiates: Buy | $31 | $11.18 | +177.28% | 1 | Feb 20, 2025 | |
LGCY Legacy Education | Maintains: Buy | $9.1 → $11 | $6.50 | +66.15% | 2 | Feb 14, 2025 | |
BNGO Bionano Genomics | Downgrades: Neutral | n/a | $4.06 | - | 1 | Nov 15, 2024 | |
SNOA Sonoma Pharmaceuticals | Initiates: Buy | $65 | $2.26 | +2,776.11% | 1 | Sep 5, 2023 | |
DKNG DraftKings | Initiates: Overweight | $52 | $33.61 | +54.72% | 1 | Jul 1, 2020 | |
SE Sea Limited | Initiates: Overweight | $130 | $120.97 | +7.46% | 1 | Jul 1, 2020 | |
TTWO Take-Two Interactive Software | Maintains: Equal-Weight | $110 → $130 | $213.24 | -39.04% | 3 | May 21, 2020 |
CeriBell
Apr 4, 2025
Initiates: Buy
Price Target: $32
Current: $14.86
Upside: +115.34%
Beta Bionics
Feb 20, 2025
Initiates: Buy
Price Target: $31
Current: $11.18
Upside: +177.28%
Legacy Education
Feb 14, 2025
Maintains: Buy
Price Target: $9.1 → $11
Current: $6.50
Upside: +66.15%
Bionano Genomics
Nov 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $4.06
Upside: -
Sonoma Pharmaceuticals
Sep 5, 2023
Initiates: Buy
Price Target: $65
Current: $2.26
Upside: +2,776.11%
DraftKings
Jul 1, 2020
Initiates: Overweight
Price Target: $52
Current: $33.61
Upside: +54.72%
Sea Limited
Jul 1, 2020
Initiates: Overweight
Price Target: $130
Current: $120.97
Upside: +7.46%
Take-Two Interactive Software
May 21, 2020
Maintains: Equal-Weight
Price Target: $110 → $130
Current: $213.24
Upside: -39.04%